Literature DB >> 410906

Association of probable defective phage particles with lysis by bacteriophage AP50 in Bacillus anthracis.

E Nagy, G Ivánovics.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 410906     DOI： 10.1099/00221287-102-1-215

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  5 in total

1.  The occurrence and taxonomic value of PBS X-like defective phages in the genus Bacillus.

Authors:  H Y Steensma; L A Robertson; J D van Elsas
Journal:  Antonie Van Leeuwenhoek       Date:  1978       Impact factor: 2.271

2.  Molecular characterization of a variant of Bacillus anthracis-specific phage AP50 with improved bacteriolytic activity.

Authors:  Shanmuga Sozhamannan; Michael McKinstry; Shannon M Lentz; Matti Jalasvuori; Farrell McAfee; Angela Smith; Jason Dabbs; Hans-W Ackermann; Jaana K H Bamford; Alfred Mateczun; Timothy D Read
Journal:  Appl Environ Microbiol       Date:  2008-09-12       Impact factor: 4.792

Review 3.  The Bacillus anthracis Cell Envelope: Composition, Physiological Role, and Clinical Relevance.

Authors:  Alice Chateau; Sander E Van der Verren; Han Remaut; Antonella Fioravanti
Journal:  Microorganisms       Date:  2020-11-26

4.  Whole genome sequencing of phage resistant Bacillus anthracis mutants reveals an essential role for cell surface anchoring protein CsaB in phage AP50c adsorption.

Authors:  Kimberly A Bishop-Lilly; Roger D Plaut; Peter E Chen; Arya Akmal; Kristin M Willner; Amy Butani; Shakia Dorsey; Vishwesh Mokashi; Alfred J Mateczun; Carol Chapman; Matroner George; Truong Luu; Timothy D Read; Richard Calendar; Scott Stibitz; Shanmuga Sozhamannan
Journal:  Virol J       Date:  2012-10-26       Impact factor: 4.099

Review 5.  Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat.

Authors:  Ewa Jończyk-Matysiak; Marlena Kłak; Beata Weber-Dąbrowska; Jan Borysowski; Andrzej Górski
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.